0001209191-23-026794.txt : 20230502
0001209191-23-026794.hdr.sgml : 20230502
20230502203200
ACCESSION NUMBER: 0001209191-23-026794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230429
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feeley Kevin
CENTRAL INDEX KEY: 0001944119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39482
FILM NUMBER: 23881325
MAIL ADDRESS:
STREET 1: C/O SEMA4 HOLDINGS CORP
STREET 2: 333 LUDLOW STREET, NORTH TOWER, 8TH FL.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneDx Holdings Corp.
CENTRAL INDEX KEY: 0001818331
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 851966622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 617 780 8742
MAIL ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Sema4 Holdings Corp.
DATE OF NAME CHANGE: 20210721
FORMER COMPANY:
FORMER CONFORMED NAME: CM Life Sciences, Inc.
DATE OF NAME CHANGE: 20200715
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-29
0
0001818331
GeneDx Holdings Corp.
WGS
0001944119
Feeley Kevin
C/O GENEDX HOLDINGS CORP.
333 LUDLOW ST, NORTH TOWER, 6TH FL.
STAMFORD
CT
06902
0
1
0
0
Chief Financial Officer
0
Class A Common Stock
2023-04-29
4
M
0
99432
0.00
A
177292
D
Restricted Stock Unit
2023-04-29
4
M
0
99432
0.00
D
Class A Common Stock
99432
298295
D
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
25% of the total shares underlying the restricted stock units vest on each of April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the restricted stock units shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.
For avoidance of doubt, all numbers presented above reflect shares issued before giving effect to the 33:1 reverse stock split the Issuer's stockholders approved on April 14, 2023, which was previously announced in the Current Report on Form 8-K filed by the Issuer on April 17, 2023, and which shall become effective on May 4, 2023.
/s/ Eunkyung Lee, Attorney-in-Fact
2023-05-02